Thermopylae Holdings Ltd., 10% Owner at AbCellera Biologics Inc. (ABCL), bought 128,176 shares at $8.05 ($1.0M) on 2022-06-14, disclosed to the SEC on 2022-06-15.
Open-market purchase of $1.0M ABCL by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.03 | 54,915 | $441K | 42.8% |
| 2 | $8.03 | 54,915 | $441K | 42.8% |
| 3 | $8.05 | 9,173 | $74K | 7.2% |
| 4 | $8.05 | 9,173 | $74K | 7.2% |
| Total | $8.03 avg | 128,176 | $1.0M | 100% |
| Filing → |
| ABCL | BUY | 2025-03-11 | $1.5M | — | Filing → |
| ABCL | BUY | 2024-08-29 | $1.5M | — | Filing → |
| ABCL | BUY | 2023-05-26 | $2.0M | — | Filing → |